Clinical Trials Browser

Phase 2 × Terminated × 13-valent pneumococcal vaccine × Clear all

NCT02309515 2021-01-19

Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis

Phase 2 Terminated

12 enrolled 8 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell